Among cause-specific cardiovascular deaths, evolocumab showed directionally favorable effects for acute MI, stroke, and heart ...
NHANES cross-sectional modeling showed cardiovascular health associated with lower overactive bladder prevalence. Component ...
Shiven B. Patel, MD, MBA, discussed strategies for overcoming tissue limits, delays, and rural access gaps in NSCLC biomarker testing at an IVBM event.
Shiven B. Patel, MD, MBA, is the head of the thoracic oncology program at Huntsman Cancer Institute, leading both the ...
Coexisting emphysema may be an important phenotype in patients with fibrotic interstitial lung disease (ILD), tied to ...
Colborn noted CMS estimates that approximately 13 million individuals could be eligible for GLP-1 therapy for weight loss ...
The 9 companies—Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and ...
“Poor model performance at this stage can have far-reaching consequences, where underestimation may delay diagnosis of lung ...
A newly validated scoring instrument extends alopecia areata assessment to the eyebrows, eyelashes, and beard. Eyebrows, ...
Data show most older adults with newly diagnosed AML expect stable or improving physical function, while oncologists ...
Updated systematic review finds GLP-1 therapies deliver substantial weight loss, with newer multiagonists and oral options ...
New multi-center registry data confirm MAC as the dominant cause of NTM pulmonary disease, while culture conversion with standard therapy still fails in nearly half of patients. This episode, "New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results